Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: [18F]fluoroestradiol (FES)
Sponsor: Asan Medical Center